Showing results (521-530 of 734) with videos related to
Sort By:
Pageof 74
Blood Cancer Journal|June 1, 2014
The role of front-line anthracycline-containing chemotherapy regimens in peripheral T-cell lymphomasR Briski, A L Feldman, N G Bailey, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 6, 2025
Evaluation of Etiologic Heterogeneity for Risk of Diffuse Large B-Cell Lymphoma Subtype Defined by the Cell of OriginGeffen Kleinstern, Dennis P Robinson, Lisa M Rimsza, et al.British Journal of Haematology|May 29, 2019
Impact of metformin use on the outcomes of newly diagnosed diffuse large B-cell lymphoma and follicular lymphomaYucai Wang, Matthew J Maurer, Melissa C Larson, et al.Leukemia & Lymphoma|September 25, 2014
Survival in patients with limited-stage peripheral T-cell lymphomasRobert Briski, Andrew L Feldman, Nathaniel G Bailey, et al.Blood Cancer Journal|July 3, 2025
Incidental vs. symptomatic diagnosis of follicular lymphoma: implications of earlier detectionSuheil Albert Atallah-Yunes, Matthew J Rees, Raphael Mwangi, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 16, 2021
Vaccination History and Risk of Lymphoma and Its Major SubtypesGeffen Kleinstern, Melissa C Larson, Stephen M Ansell, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|December 21, 2010
Specificity of IRF4 translocations for primary cutaneous anaplastic large cell lymphoma: a multicenter study of 204 skin biopsiesDavid A Wada, Mark E Law, Eric D Hsi, et al.Leukemia & Lymphoma|August 20, 2005
The effect of absolute lymphocyte count recovery kinetics on survival after autologous stem cell transplantation for non-Hodgkin's lymphomaYinlee Yoong, Luis F Porrata, David J Inwards, et al.Blood|May 19, 2019
Targeting glycogen synthase kinase 3 for therapeutic benefit in lymphomaXiaosheng Wu, Mary Stenson, Jithma Abeykoon, et al.Blood Cancer Journal|August 17, 2023
Metabolic PET/CT analysis of aggressive Non-Hodgkin lymphoma prior to Axicabtagene Ciloleucel CAR-T infusion: predictors of progressive disease, survival, and toxicityWilliam G Breen, Jason R Young, Matthew A Hathcock, et al.Pageof 74